Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis-Reference-Cited by-同舟云学术

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Published:2012-12-20 Issue:25 Volume:367 Page:2396-2406
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Ruperto Nicolino,Brunner Hermine I.,Quartier Pierre,Constantin Tamás,Wulffraat Nico,Horneff Gerd,Brik Riva,McCann Liza,Kasapcopur Ozgur,Rutkowska-Sak Lidia,Schneider Rayfel,Berkun Yackov,Calvo Inmaculada,Erguven Muferet,Goffin Laurence,Hofer Michael,Kallinich Tilmann,Oliveira Sheila K.,Uziel Yosef,Viola Stefania,Nistala Kiran,Wouters Carine,Cimaz Rolando,Ferrandiz Manuel A.,Flato Berit,Gamir Maria Luz,Kone-Paut Isabelle,Grom Alexei,Magnusson Bo,Ozen Seza,Sztajnbok Flavio,Lheritier Karine,Abrams Ken,Kim Dennis,Martini Alberto,Lovell Daniel J.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1205099

Cited by 569 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The latest advances in the use of biological DMARDs to treat Still’s disease;Expert Opinion on Biological Therapy;2024-01-29

2. Recent advances and evolving concepts in Still’s disease;Nature Reviews Rheumatology;2024-01-11

3. Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022;Pediatric Rheumatology;2024-01-05

4. GH therapy in children with juvenile idiopathic arthritis: a four-decade review;Clinical Pediatric Endocrinology;2024

5. Biological and clinical roles of IL-18 in inflammatory diseases;Nature Reviews Rheumatology;2023-12-11